The global urology supplements market size was estimated at USD 1.77 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.14% from 2024 to 2030. The market has observed significant growth in recent years owing to increasing awareness, prevalence of kidney related problems, and rising geriatric population. Furthermore, the growing demand for safe and effective alternatives to traditional medications is anticipated to fuel the market growth.
The COVID-19 pandemic has slightly impacted the urology supplements market, with various factors contributing to a downturn. Due to the supply chain disruptions and economic uncertainties that have hindered market growth, individuals prioritized essential expenses over non-urgent purchases. Additionally, the shift towards telemedicine has limited opportunities for in-person consultations, reducing opportunities for healthcare providers to recommend supplements. Overall, these challenges have resulted in slight negative impact on the market, necessitating innovative strategies to adapt to the changing landscape and regain market momentum.
The aging demographic presents an irreversible global trend that serves as a pivotal driver for market advancement, particularly in the realm of urology supplements. According to the World Health Organization (WHO), the global aging population, comprising individuals aged 65 and above, is expected to double over the next two decades. This demographic segment constitutes a critical target audience for urology supplement companies, fueling the demand for such products. While the highest sales typically occur within the adult category (individuals aged 25 to 65), the penetration rate is notably higher among the geriatric population. In fact, the 65-and-above age group accounts for approximately 30% of urology supplement sales worldwide.
Moreover, the accessibility to urology supplements is increasing due to the emergence of e-commerce. Although it is difficult to buy certain supplements online due to a lack of product knowledge and suitability concerns, sales of these products have continued to increase. Some of the key market players are striving to improve their online shopping experience. Thus, accessibility to these products is increasing through online retail.
The market growth stage is high, and the pace of growth is accelerating. It is expected to have a steady increase in demand and adoption of urology supplements, likely driven by factors such as growing adoption of e-commerce, awareness of urological health issues, aging population, and advancements in supplement formulations. As consumer interest and healthcare provider recommendations continue to grow, alongside ongoing research and development efforts, the market is poised for further acceleration in its growth trajectory.
Partnerships and collaboration activities are moderately prevalent, reflecting a medium level of engagement within the industry. This suggests that while there is cooperation between various stakeholders such as supplement manufacturers, healthcare providers, research institutions, and distribution channels, it may not be as extensive or intensive as observed in other sectors. These partnerships likely focus on areas such as product development, distribution agreements, clinical trials, and educational initiatives aimed at promoting urological health.
Regulatory bodies are intensifying their scrutiny of urology supplements market, driven by worries regarding safety, unverified claims, and the risk of misuse. This heightened oversight may lead to the implementation of more stringent regulations aimed at safeguarding consumer well-being.
The market currently exhibits a moderate level of product expansion, with expectations for growth over time fueled by two key factors: the increasing geriatric population and the prevalence of unhealthy lifestyles among individuals. As the aging demographic expands and lifestyle-related urological issues become more prevalent, there is a growing demand for a broader range of urology supplements catering to diverse needs. This trend is likely to drive manufacturers to innovate and expand their product offerings, introducing new formulations tailored to address specific urological concerns arising from age-related and lifestyle-related factors. Consequently, the market is anticipated to witness a gradual increase in product expansion in response to evolving consumer needs and market dynamics.
The urology supplements industry currently demonstrates a moderate level of regional expansion, with expectations for growth driven by an expanding consumer base over time. As awareness of urological health issues grows globally and access to healthcare improves in emerging markets, there is a rising demand for urology supplements across different regions. Factors such as changing demographics, increasing disposable income, and evolving healthcare infrastructure contribute to the expanding consumer base. Consequently, the market is anticipated to experience a gradual but notable increase in regional expansion as manufacturers and distributors seek to capitalize on emerging opportunities in diverse geographic markets.
The multi-ingredient segment held the largest market share in 2023 and is anticipated to grow at the higher CAGR of 8.71% during 2024-2030. The primary factors such as higher demand for comprehensive care products, rising demand for natural and holistic solutions, and synergistic effects from multi-ingredient formulations are driving the segment’s growth. For instance, in December 2020, Labiana pharmaceuticals announced the launch of precyst, a novel multi-ingredient supplement that include D-mannose and cranberry extract designed to support urinary system health in women.
The single ingredient segment is expected to register a significant CAGR from 2024 to 2030. Single ingredient supplements often offer specific benefits for urological health, such as supporting prostate health, promoting urinary tract function, or addressing issues like urinary incontinence. Consumers are increasingly seeking targeted solutions for their health concerns, which drives the demand for single ingredient supplements.
The urinary tract infection (UTI) segment dominated the market with a revenue share of 37.31% in 2023 and is anticipated to grow at the highest CAGR over the forecast period. Increased awareness about UTIs and their risk factors has led to greater consumer interest in preventative measures, including the use of supplements. The high prevalence of UTIs means there is a significant market demand for supplements aimed at preventing and managing these infections. There are several companies providing urology supplements for UTIs. For instance Azo, Now Foods, and Swanson which include Cranberry Caps and Urinary Tract Essentials capsules.
The kidney health segment is expected to grow at a significant CAGR over the forecast period. Awareness about the importance of kidney health and the impact of lifestyle factors on kidney function is increasing among consumers. Individuals are becoming more proactive about maintaining their kidney health through diet, lifestyle modifications, and supplementation. This heightened awareness is anticipated to drive the demand for urology supplements specifically formulated to support kidney function and health.
Based on formulation, the market is segmented into capsules, softgels, tablets, liquid, and others. The capsule dominated the market with share of 38.02% in 2023. Capsules are one of the most convenient dosage forms for supplements. They are easy to swallow and do not have a strong taste or odor, making them more palatable for consumers compared to other forms such as tablets or powders. This ease of use contributes to the popularity of capsules among consumers, driving their dominance in the market.
The softgels segment is expected to grow at the fastest CAGR from 2024 to 2030. Softgel capsules typically contain active ingredients that are dissolved or suspended in oil or other lipid-based carriers. This enhances the bioavailability of the nutrients, allowing for better absorption in the body compared to other dosage forms such as tablets or traditional capsules. The increased bioavailability of softgels results in more effective delivery of nutrients; driving their popularity among consumers seeking optimal health benefits.
Based on distribution channel, the market is segmented into brick & mortar and e-commerce. The brick & mortar segment dominated the market with a revenue share in 2023. The rising trend among medical professionals to recommend supplements for urological health issues such as urinary tract health, prostate health, and bladder function is anticipated to boost brick & mortar segment in the urology supplements market.
The e-commerce segment is expected to grow at the fastest CAGR from 2024 to 2030. The online market for urology supplements is poised for growth as consumers take more control of their health decisions and the utilization of e-commerce platforms continues to surge. For instance, in May 2023, Uqora initiated a strategic expansion of its urinary tract health products across various channels, aiming to reach a wider audience in the urology supplements market. Such developments are propelling the growth of the segment during the forecast period.
North America holds a significant revenue share for the urology supplements market. The market’s growth is driven by factors such as heightened awareness of urological health, the escalating prevalence of lifestyle-related urological conditions, and the convenient availability of supplement-based solutions. Furthermore, the increasing awareness of urological health and shifts in lifestyle patterns have spurred a surge in consumers seeking noninvasive, enduring approaches to enhance their overall urological well-being, fostering robust demand for urology supplements across the region.
The urology supplements market in the U.S. is expected to grow over the forecast period due to presence of large number of local market players present in U.S. which are undergoing various strategic initiatives such as collaborations and partnerships.
Europe was identified as a lucrative region in the urology supplements industry. This can be attributed to the increasing awareness about healthy lifestyle and changing perspectives toward health.
The urology supplements market in the UK is expected to grow significantly over the forecast period. Increasing geriatric population, growing demand for organic supplements, and rising preference for supplements are anticipated to drive the market growth.
The France urology supplements market is expected to grow over the forecast period due to the increasing awareness among consumers and rising prevalence of UTI in the country.
The urology supplements market in Germany is expected to grow over the forecast period due to the presence of a substantial number of local providers offering supplements.
Asia Pacific dominated the urology supplements market with a revenue share of 35.35% in 2023 and is anticipated to grow at the fastest CAGR from 2024 to 2030. There is a growing awareness and interest in health & wellness among consumers across the APAC region. People are becoming more conscious of their lifestyle habits and are seeking urology products that promote overall well-being. As disposable income rises in APAC countries, consumers are willing to spend more on health-enhancing products.
The urology supplements market in China is expected to grow over the forecast period due to rising geriatric population and growing demand for urology supplements.
The Japan urology supplements market is expected to grow over the forecast period due to factors such as rapidly aging population, rising health consciousness, and growing demand for preventive healthcare.
The urology supplements market in India is expected to grow over the forecast period due to its large population and increasing focus on personal health & wellness and growing prevalence of UTIs.
Middle Eastern countries such as Saudi Arabia, Qatar, United Arab Emirates (UAE), and Kuwait are prospering economies witnessing significant growth in the demand for urology supplements. This surge is driven by several factors, including a growing middle-class population, increasing disposable incomes, and a rising awareness of urological health and wellness. Rapid urbanization and evolving lifestyles have contributed to a prevalence of sedentary occupations and unhealthy dietary habits, leading to a higher incidence of urological issues such as urinary tract infections, kidney stones, and prostate problems.
The urology supplements market in Saudi Arabia is expected to grow over the forecast period. Majority of the people residing in Saudi Arabia live a modern lifestyle, and availability of fast food caused a shift in dietary habits which is anticipated to boost the market.
Product approvals are helping the market players increase the reach of their products in the market and improve the availability of their products in diverse geographical areas, along with expansion as a strategy to enhance production/research activities. In addition, several market players are acquiring smaller players to strengthen their market position. This strategy enables companies to increase their capabilities, expand their product portfolios, and improve their competencies.
The following are the leading companies in the urology supplements market. These companies collectively hold the largest market share and dictate industry trends.
In January 2024, Theralogix announces the launch of Mannose One, a cutting-edge dietary supplement offering enhanced urinary tract protection. Theralogix introduces Mannose One as the sole d-mannose supplement independently tested and content-certified.
In August 2023, Modicare Limited, a prominent direct-selling firm in India, introduces Sci-Vedic products specifically tailored for men and women in its 'Well' line, addressing targeted nutrition and wellness needs. This expansion underscores Modicare's commitment to offering a diverse range of products tailored to support various health. This is anticipated to fuel the growth of the market.
In April 2022, PharmaLinea introduces a new line of prebiotic products, along with additions to its offerings in iron and UTI supplements.
In September 2021, Hims & Hers introduces a new dietary supplement targeting the reduction of UTIs, addressing the prevalent issue of urinary tract infections, which affect over half of adult women in the U.S. at some point in their lives.
In April 2021, Vibegron (Gemtesa) announced their accessibility in the United States for adults dealing with overactive bladder (OAB), presenting symptoms including urge urinary incontinence (UUI), urgency, and increased urinary frequency.
Report Attribute |
Details |
Market size value in 2024 |
USD 1.90 billion |
Revenue forecast in 2030 |
USD 3.04 billion |
Growth rate |
CAGR of 8.14% from 2024 to 2030 |
Actual data |
2018 - 2023 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Type, application, formulation, distribution channel, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia, UAE; Kuwait |
Key companies profiled |
Theralogix; Nature's Bounty; Solaray; Puritan's Pride; Schiff Nutrition; ZAHLER; Natrol, LLC.; Biotexlife; Himalaya Wellness.; Himalayan Organics |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global urology supplements market report based on type, application, formulation, distribution channel, and region:
Type Outlook (Revenue, USD Billion, 2018 - 2030)
Multi-ingredient
Single ingredient
Application Outlook (Revenue, USD Billion, 2018 - 2030)
Urinary Tract infections
Kidney Health
Prostate Health
Bladder Health
Formulation Outlook (Revenue, USD Billion, 2018 - 2030)
Capsules
Softgels
Tablets
Liquid
Others
Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
Brick & Mortar
E-commerce
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global urology supplements market size was estimated at USD 1.77 billion in 2023 and is expected to reach USD 1.90 billion in 2023.
b. The global urology supplements market is expected to grow at a compound annual growth rate of 8.14% from 2024 to 2030 to reach USD 3.04 billion by 2030.
b. The urinary tract infection segment dominated the market for urology supplements and held the largest revenue share of 37.31% in 2023.
b. Some key players operating in the urology supplements market include Theralogix, Nature's Bounty, Solaray, Puritan's Pride, Schiff Nutrition, ZAHLER, Natrol, LLC., Biotexlife, Himalaya Wellness., and Himalayan Organics
b. Key factors that are driving the market growth include growing geriatric population, increasing awareness among consumers, and rising consumer base in several regions.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."